Daiichi Sankyo poised to enter Japan's generics sector
26 February 2010
Ian Haydock
Daiichi Sankyo is to set up a new operation in Japan for the manufacture and marketing of its own mature products as well as generics sourced from
Ranbaxy Laboratories, in a move designed to build on its 2008 acquisition of the Indian firm.
Tokyo-based Daiichi Sankyo Espha will be formed on April...
Please Login to read the full article.
26 February 2010
Ian Haydock
Tokyo-based Daiichi Sankyo Espha will be formed on April...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Lonza and Fosun Chinese biopharm generic JV will "protect customer IP"
- Hybrid growth: Ranbaxy starts development of generics for Daiichi Sankyo in China
- Mylan suit pushes FDA to decide immediately on Ranbaxy ANDA for generic Lipitor
- Ranbaxy's 2010 profit surges but flat sales seen ahead
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
